Neuspera key facts
- Developer of implantable medical devices designed to improve the lives of patients battling chronic illness.
- Neuspera’s last known valuation is $165.0M.
- It has raised $128.4M; the latest was Later Stage VC ($24.2M) in Jun 2024.
- Notable investors include Alumni Ventures, MedTech Innovator, Stanford University, Revelation Partners, PEAK6 Strategic Capital — 16 tracked in total.
- Status: Privately Held (backing).
Who backs Neuspera
16+- ·The complete investor list: 16 names
- ·Watch Neuspera: the Monday email on marks, rounds and moves
Neuspera funding rounds
No funding rounds for Neuspera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Neuspera valuation
Neuspera's last known valuation is $165 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Neuspera investors
16 investors are on record for Neuspera, including Alumni Ventures, MedTech Innovator, Stanford University and Revelation Partners.
About Neuspera
Developer of implantable medical devices designed to improve the lives of patients battling chronic illness. The company offers implantable neuromodulation devices that use mid-field powering techniques and can be implanted deep, enabling patients to get treatment options that are less invasive and more adaptable.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2013
- Employees
- 43
- Website
- neuspera.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Neuspera’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.